3/27
06:02 am
jspr
Form EFFECT Jasper Therapeutics,
Low
Report
Form EFFECT Jasper Therapeutics,
3/26
04:53 pm
jspr
Form 424B5 Jasper Therapeutics,
Medium
Report
Form 424B5 Jasper Therapeutics,
3/19
04:43 pm
jspr
Form 8-K Jasper Therapeutics, For: Mar 14
Low
Report
Form 8-K Jasper Therapeutics, For: Mar 14
3/19
04:12 pm
jspr
Form S-3 Jasper Therapeutics,
Low
Report
Form S-3 Jasper Therapeutics,
2/28
09:21 am
jspr
Form 10-K Jasper Therapeutics, For: Dec 31
Low
Report
Form 10-K Jasper Therapeutics, For: Dec 31
2/27
08:05 am
jspr
Form 8-K Jasper Therapeutics, For: Feb 27
Low
Report
Form 8-K Jasper Therapeutics, For: Feb 27
2/18
05:31 pm
jspr
Form 4 Jasper Therapeutics, For: Feb 13 Filed by: MARTELL RON
Medium
Report
Form 4 Jasper Therapeutics, For: Feb 13 Filed by: MARTELL RON
2/18
05:31 pm
jspr
Form 4 Jasper Therapeutics, For: Feb 13 Filed by: Mahal Jeetinder Singh
Medium
Report
Form 4 Jasper Therapeutics, For: Feb 13 Filed by: Mahal Jeetinder Singh
2/18
05:30 pm
jspr
Form 4 Jasper Therapeutics, For: Feb 13 Filed by: Tucker Edwin Jonathan
Medium
Report
Form 4 Jasper Therapeutics, For: Feb 13 Filed by: Tucker Edwin Jonathan
2/18
05:30 pm
jspr
Form 4 Jasper Therapeutics, For: Feb 13 Filed by: CROSS HERB
Medium
Report
Form 4 Jasper Therapeutics, For: Feb 13 Filed by: CROSS HERB
2/11
04:01 pm
jspr
Form SCHEDULE 13G/A Jasper Therapeutics, Filed by: Soleus Capital Master Fund, L.P.
Low
Report
Form SCHEDULE 13G/A Jasper Therapeutics, Filed by: Soleus Capital Master Fund, L.P.